Publications by authors named "Rogerio Gaspar"

Claim this Profile
P
Prosthetic Mitral Valve Fungal Endocarditis: Challenges in Diagnosis and Management.
André L Tyszka, Maria Emilia A Machado, Harissa S El Ghoz, Giovanna S Tyszka, Mateus A Aboboreira, Rogerio M Gaspar

JACC Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A World Health Organization tool for assessing research ethics oversight systems.
Carl H Coleman, Alireza Khadem, John C Reeder, Hiiti B Sillo, Rogerio Gaspar

Bull World Health Organ· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHO-listed authorities (WLA) framework: transparent evidence-based approach for promoting regulatory reliance towards increased access to quality-assured medical products.
Alireza Khadem Broojerdi, Anna Laura Salvati, Mohammed Refaat Abdelfattah, Razieh Ostad Ali Dehaghi, Hiiti B Sillo, Rogerio Gaspar

Front Med (Lausanne)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation.
Philip R Krause, Narendra Arora, William Dowling, César Muñoz-Fontela, Simon Funnell, Rogerio Gaspar

Vaccine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations in boosting COVID-19 vaccine immune responses.
Philip R Krause, Thomas R Fleming, Richard Peto, Ira M Longini, J Peter Figueroa, Rogerio Gaspar

Lancet· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Variants and Vaccines.
Philip R Krause, Thomas R Fleming, Ira M Longini, Richard Peto, Sylvie Briand, Rogerio Gaspar

N Engl J Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence Decision.
Rogério Sá Gaspar, Beatriz Silva-Lima, Fernando Magro, Armando Alcobia, Fernando Leal da Costa

Front Med (Lausanne)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging communities in the field of nanomedicine.
Blanka Halamoda-Kenzaoui, Simon Baconnier, Thierry Bastogne, Didier Bazile, Patrick Boisseau, Rogério Gaspar

Regul Toxicol Pharmacol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming.
Eva Zupančič, Caterina Curato, Maria Paisana, Catarina Rodrigues, Ziv Porat, Rogério Gaspar

J Control Release· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational Peptide-associated Nanosystems: Promising Role as Cancer Vaccines.
Eva Zupančič, Carina Peres, Ana I Matos, João Lopes, João N Moreira, Rogério S Gaspar

Curr Top Med Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy.
M Luísa Corvo, Ana Soraia Mendo, Sara Figueiredo, Rogério Gaspar, Miguel Larguinho

Pharm Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of Dendritic Cells by Nanotechnology-Based Immunotherapeutic Strategies.
Joana Mogrão, Catarina A da Costa, Rogério Gaspar, Helena F Florindo

J Biomed Nanotechnol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory aspects on nanomedicines.
Vanessa Sainz, João Conniot, Ana I Matos, Carina Peres, Eva Zupancic, Rogério S Gaspar

Biochem Biophys Res Commun· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking.
João Conniot, Joana M Silva, Joana G Fernandes, Liana C Silva, Rogério Gaspar

Front Chem· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to regulate nonbiological complex drugs (NBCD) and their follow-on versions: points to consider.
Huub Schellekens, Sven Stegemann, Vera Weinstein, Jon S B de Vlieger, Beat Flühmann, Rogério Gaspar

AAPS J· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune system targeting by biodegradable nanoparticles for cancer vaccines.
Joana M Silva, Mafalda Videira, Rogério Gaspar, Véronique Préat, Helena F Florindo

J Control Release· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticles: Pushed off target with proteins.
Rogério Gaspar

Nat Nanotechnol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Rogério Gaspar, Buket Aksu, Alain Cuine, Meindert Danhof, Milena Jadrijevic-Mladar Takac

Eur J Pharm Sci· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicine(s) under the microscope.
Ruth Duncan, Rogerio Gaspar

Mol Pharm· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.
Ann H Klopp, Lara Lacerda, Anshul Gupta, Bisrat G Debeb, Travis Solley, Rogério Gaspar

PLoS One· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.
Rogério Gaspar, Ruth Duncan

Adv Drug Deliv Rev· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals.
Rogério Gaspar

Nanomedicine (Lond)· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.
Cristina Fonseca, Sérgio Simões, Rogério Gaspar

J Control Release· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity.
João N Moreira, Tatsuhiro Ishida, Rogério Gaspar, Theresa M Allen

Pharm Res· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis